| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |